智通财经APP讯，中证国际(00943)发布公告，董事会提出的计划包括：股份合并;削减股份溢价;更改每 手买卖单位;债务资本化;及供股。 于计划完成后，预期本集团的负债将透过债务资本化减少，而新资本将透过供股筹集，整体而言，本集 团的财务状况将获得改善。此外，于股份合并及更改每手买卖单位后，预期股份的成交价及每手买卖单 位的价值将会增加，从而使本公司符合上市规则的买卖规定。 董事会建议将每20股每股面值0.00004港元的已发行及未发行现有股份合并为1股每股面值0.0008港元的 合并股份。 于本公告日期，本公司法定股本为10亿港元，分为250000亿股每股面值0.00004港元的现有股份，其中 128.24亿股现有股份为已发行及入账列作缴足。假设于本公告日期至股东特别大会日期期间概无进一步 发行或购回现有股份，紧随股份合并生效后但于债务资本化及供股完成前，本公司的法定股本将为10亿 港元，分为12500亿股每股面值0.0008港元的合并股份，其中6.41亿股合并股份将为已发行。 董事会建议将每手买卖单位从8000股现有股份更改为16000股合并股份。 于2025年5月15日交易时段后，本公司与认购人I订立债 ...

Financial Performance - Revenue for the six months ended December 31, 2024, was HKD 64,022,000, representing a 35.3% increase from HKD 47,291,000 in the same period of 2023[4] - Total income for the same period was HKD 64,532,000, up 35.5% from HKD 47,575,000 year-on-year[4] - Gross profit increased to HKD 16,300,000, a rise of 15.1% compared to HKD 14,160,000 in the previous year[4] - Operating loss narrowed to HKD 10,466,000 from HKD 12,831,000, indicating improved operational efficiency[4] - The loss attributable to the company’s owners for continuing operations was HKD 36,945,000, compared to HKD 20,519,000 in the prior year[5] - Total comprehensive loss for the period was HKD 15,745,000, significantly reduced from HKD 925,483,000 in the previous year[5] - The basic loss per share for continuing operations was HKD 0.29, compared to HKD 0.17 in the previous year[5] - The group reported a period loss of approximately HKD 89,153,000 for the six months ended December 31, 2024, compared to a loss of HKD 694,210,000 for the same period in 2023[25] - The loss from discontinued operations was approximately HKD 52,208,000, down from HKD 673,691,000 in the previous period[52] Assets and Liabilities - Non-current assets totaled HKD 649,085,000 as of December 31, 2024, compared to HKD 628,002,000 at the end of June 2024[6] - Current liabilities decreased to HKD 187,861,000 from HKD 2,139,421,000, reflecting a significant reduction in financial obligations[6] - The company reported a net asset value of HKD 281,880,000, up from HKD 115,049,000 in the previous period[7] - The company has a net current liability of approximately HKD 103,150,000 as of December 31, 2024, raising significant uncertainty regarding its ability to continue as a going concern[12] - The total bank and cash balance as of December 31, 2024, was approximately HKD 2,339,000, a significant decrease from HKD 20,135,000 as of June 30, 2024[35] - The company's total borrowings as of December 31, 2024, were approximately HKD 28,963,000, a decrease from HKD 1,058,801,000 as of June 30, 2024[37] - The current liabilities net amount as of December 31, 2024, was approximately HKD 103,150,000, down from HKD 473,718,000 as of June 30, 2024, resulting in a current ratio of 0.45[75] - Total debt and borrowings amounted to approximately HKD 327,063,000 as of December 31, 2024, significantly reduced from HKD 1,344,401,000 as of June 30, 2024[76] Cash Flow - The company reported a net cash outflow from operating activities of HKD 11,948,000 for the six months ended December 31, 2024, compared to a net inflow of HKD 14,101,000 in the same period of 2023[9] - The company reported a net cash outflow from investing activities of HKD 16,218,000 for the six months ended December 31, 2024[9] - The company’s cash balance in Renminbi was approximately HKD 185,000 as of December 31, 2024, a significant drop from HKD 16,131,000 as of June 30, 2024[35] Business Operations - The company plans to cease its property development and first-tier land development business in China following the sale of its wholly-owned subsidiary[10] - The company is implementing cost-saving measures to improve its operating cash flow and financial condition[14] - The company has issued new shares amounting to HKD 21,028,000 due to debt capitalization[8] - The company completed the sale of its entire equity interest in Hong Kong Zhongzheng City Investment Co., Ltd. for HKD 53,700,000 on July 22, 2024[44] - The company has terminated its property development and first-level land development business in China, completing the sale of all related equity and loans for HKD 53,700,000[67] Segment Performance - Revenue from the manufacturing and sales of healthcare and household products increased to HKD 62,575,000 from HKD 47,291,000, reflecting a growth of approximately 32.2%[16] - The segment loss for continuing operations was HKD 36,880,000, compared to a loss of HKD 20,519,000 in the prior year, indicating an increase in losses of approximately 79.8%[16] - The gross profit margin for the health and household products segment was approximately 22.9%, down from about 29.3% in the first half of 2023/2024, attributed to increased material costs due to a surge in sales orders[56] - The coal mining segment recorded royalty income of approximately HKD 1,447,000 and segment profit of about HKD 903,000 during the period, compared to a segment loss of approximately HKD 356,000 in the first half of 2023/2024[63] Impairment and Provisions - The company recognized impairment losses on other receivables of approximately HKD 16,086,000 and on loans and interest of approximately HKD 2,616,000 during the period[53] - The group recognized an impairment loss of approximately HKD 405,300,000 related to development properties held for sale in Nanjing as of December 31, 2023[23] - The impairment loss on interests in associates was recorded at HKD 327,144,000 for the six months ended December 31, 2023[22] Shareholder Information - Major shareholders include Low Thiam Herr with 2,206,750,364 shares (17.21%), Yang Bin with 2,102,817,178 shares (16.40%), and Lim Kim Chai with 1,569,420,951 shares (12.24%) as of December 31, 2024[88] - The company’s total issued and paid-up shares increased to 12,824,484,010 as of December 31, 2023, from 10,721,666,832 on July 1, 2023, due to debt capitalization[20] Corporate Governance - The company confirmed compliance with the standard code for securities transactions by all directors during the six months ending December 31, 2024[92] - The audit committee, consisting of three independent non-executive directors, has reviewed the unaudited interim financial statements for the six months ending December 31, 2024[84] - The company has adhered to all corporate governance practices as stipulated in the listing rules during the six months ending December 31, 2024[93]

Financial Performance - Revenue for the six months ended December 31, 2024, was HKD 64,022,000, representing a 35.3% increase from HKD 47,291,000 in the same period of 2023[2] - Total income for the same period was HKD 64,532,000, up 35.6% from HKD 47,575,000[2] - Gross profit increased to HKD 16,300,000, a rise of 15.1% compared to HKD 14,160,000[2] - Operating loss for the period was HKD 10,466,000, an improvement from a loss of HKD 12,831,000 in the previous year[2] - Loss before tax from continuing operations was HKD 36,880,000, compared to HKD 20,519,000 in the prior period[3] - Total loss for the period was HKD 92,615,000, significantly reduced from HKD 929,060,000 in the same period last year[5] - Basic loss per share for continuing and discontinued operations was HKD 0.70, down from HKD 5.62[5] - The group reported total revenue of HKD 64,532,000 for the six months ended December 31, 2024, a decrease of 23.3% compared to HKD 84,070,000 for the same period in 2023[18] - The group incurred a total loss of HKD 36,880,000 for the six months ended December 31, 2024, compared to a loss of HKD 20,519,000 for the same period in 2023[16] - The group reported a loss of approximately HKD 89,153,000 for the six months ended December 31, 2024, compared to a loss of HKD 694,210,000 for the same period in 2023[28] - The loss attributable to the company's owners for the period was approximately HKD 89,153,000, a significant decrease from HKD 694,210,000 in the previous period[67] - The loss from discontinued operations was approximately HKD 52,208,000, compared to HKD 673,691,000 in the previous period[69] Assets and Liabilities - Non-current assets totaled HKD 649,085,000, slightly up from HKD 628,002,000[6] - The group’s total assets amounted to HKD 146,093,000, while total liabilities were HKD 124,672,000 as of December 31, 2024[16] - The group has a net current liability of approximately HKD 103,150,000 as of December 31, 2024, indicating significant uncertainty regarding its ability to continue as a going concern[11] - Total borrowings as of December 31, 2024, are approximately HKD 28,963,000, a decrease from HKD 1,058,801,000 as of June 30, 2024, with a significant portion classified as current liabilities[44] - Shareholder loans total approximately HKD 298,100,000 as of December 31, 2024, with a portion of HKD 250,000,000 extended to 2027 for repayment[50] - The company's debt ratio was reported at 116.0% as of December 31, 2024, significantly lower than 1,168.5% as of June 30, 2024[99] Cash Flow and Financing - The group is implementing cost-saving measures to improve its operating cash flow and financial position[15] - Interest income from lending activities increased to HKD 510,000 for the six months ended December 31, 2024, compared to HKD 284,000 in the previous year[18] - The group’s financing costs for the six months ended December 31, 2024, totaled HKD 14,515,000, a significant decrease from HKD 109,358,000 in the same period of 2023[20] - The group’s management has prepared cash flow forecasts for at least the next 12 months to assess liquidity needs[13] - The group's bank and cash balances as of December 31, 2024, are approximately HKD 2,339,000, a decrease from HKD 20,135,000 as of June 30, 2024, with significant restrictions on certain funds[41] - The current ratio as of December 31, 2024, was 0.45, down from 0.78 as of June 30, 2024, indicating a decline in liquidity[97] Business Operations and Strategy - The company plans to terminate its property development and land development business in China following the sale of its wholly-owned subsidiary[9] - The healthcare and household products segment generated revenue of approximately HKD 62,575,000, an increase of about 32.3% compared to HKD 47,291,000 in the first half of 2023/2024, primarily due to major customers accelerating inventory replenishment in Q4 2024[72] - The company strategically expanded its B2B and B2C online business, enhancing product competitiveness and global customer acquisition through AI-driven customization tools and dynamic pricing models tailored for bulk purchasing[74] - The flagship product, a sonic vibration electric toothbrush, is set to begin mass production in May 2025, aiming to create new revenue streams[92] - The company maintains a cautious outlook for its coal mining business due to declining coal prices in Indonesia and an oversupply in the global market[94] Impairments and Losses - The group recognized an impairment loss of approximately HKD 405,300,000 related to development properties for the six months ended December 31, 2023[26] - The group recognized an impairment loss of approximately HKD 16,086,000 related to other receivables for the six months ended December 31, 2024[26] - The company has recognized additional impairment of approximately HKD 2,616,000 for accounts receivable loans and interest due to increased credit risk as of December 31, 2024[39] Shareholder and Governance - The major shareholder, Mr. Low Thiam Herr, has committed to providing financial support to the company[15] - The group did not declare any interim dividend for the six months ended December 31, 2024, consistent with the previous year[27] - The board of directors consists of two executive directors, one non-executive director, and four independent non-executive directors[111] Market and Economic Conditions - The United States remained the largest market for this segment, accounting for approximately 83.4% of revenue, while Germany contributed about 3.8%[74] - The company holds a 35% stake in Pacific Memory Sdn Bhd, which is engaged in commercial development in Malaysia, and is cautiously optimistic about new opportunities in the Malaysian real estate sector[86]

Financial Performance - The total revenue for the year ended June 30, 2024, was HKD 147,242,000, a significant decrease of 83.1% compared to HKD 869,637,000 in the previous year[2] - The gross profit for the same period was HKD 22,989,000, down 91.0% from HKD 253,687,000 in the prior year[2] - The operating loss for the year was HKD 38,719,000, compared to an operating profit of HKD 405,192,000 in the previous year[2] - The net loss attributable to the owners of the company was HKD 699,345,000, a stark contrast to a profit of HKD 69,131,000 in the previous year[3] - Total revenue for the year was HKD 148,499,000, a significant decrease of 83.0% compared to HKD 872,910,000 in the previous year[9] - The reported segment loss for the year ended June 30, 2024, was HKD (758,313,000), compared to HKD (181,191,000) in the previous year, indicating a substantial increase in losses[19] - The company reported a pre-tax loss of HKD 892,378,000 for the fiscal year 2024, compared to a profit of HKD (199,761,000) in 2023[25] - The company recorded a comprehensive loss attributable to owners of approximately HKD 699,345,000, compared to a profit of HKD 69,131,000 in the previous fiscal year[84] Assets and Liabilities - The total assets decreased to HKD 1,665,703,000 from HKD 2,061,548,000, reflecting a decline of 19.2%[4] - The current liabilities exceeded current assets, resulting in a net current liability of HKD 473,718,000, compared to a net current asset of HKD 68,305,000 in the previous year[4] - The company’s equity attributable to owners decreased to HKD 293,066,000 from HKD 974,130,000, a decline of 69.9%[6] - The total assets reported as of June 30, 2024, were HKD 2,293,705,000, down from HKD 3,025,006,000 in 2023, a decrease of about 24.2%[19] - The total liabilities as of June 30, 2024, were HKD 2,178,656,000, compared to HKD 2,062,470,000 in the previous year, indicating an increase of approximately 5.6%[19] - The group's current liabilities net amount was approximately HKD 473,718,000, resulting in a current ratio of 0.78, down from 1.03 on June 30, 2023[107] - Total debt and borrowings amounted to approximately HKD 1,344,401,000 as of June 30, 2024, compared to HKD 1,363,956,000 on June 30, 2023[108] Revenue Breakdown - Revenue from property development was HKD 46,664,000, down 93.3% from HKD 697,216,000 year-on-year[10] - Revenue from the manufacturing and sales of health and household products was HKD 100,278,000, a decline of 42.0% from HKD 172,421,000 in the previous year[10] - Coal mining royalty income was HKD 300,000, with no revenue reported in the previous year[9] - Interest income from lending activities decreased to HKD 1,257,000, down 61.6% from HKD 3,273,000 year-on-year[9] - Revenue from the United States for the year ended June 30, 2024, was HKD 75,620,000, down from HKD 140,165,000 in 2023, a decline of approximately 46.1%[21] Impairment and Losses - The company reported a significant impairment loss on development properties amounting to HKD 196,443,000[2] - The impairment loss recognized for Chengde Jinyu's equity was approximately HKD 288,775,000 in 2024, up from HKD 75,860,000 in 2023, reflecting deteriorating asset recoverability[36] - The group recognized an impairment loss of approximately HKD 68,155,000 on receivables from Chengde Jinyu in 2024, whereas there was no such loss in 2023[37] - The total impairment provision for receivables increased to HKD 44,987,000 in 2024 from HKD 38,058,000 in 2023, indicating rising credit risk[40] - The company recognized a reversal of impairment loss of HKD (31,761,000) related to exploration and evaluation assets due to the approval of mining operations by the Indonesian government[33] Cash Flow and Financing - The company reported a net cash outflow from operating activities of approximately HKD 21,120,000 for the year ended June 30, 2024, against current liabilities of about HKD 473,718,000[60] - The company has not made scheduled repayments on certain borrowings as of June 30, 2024, raising significant doubts about its ability to continue as a going concern[60] - The auditor expressed concerns regarding the recoverability of exploration and evaluation assets, which had a zero balance as of June 30, 2023, and the appropriateness of impairment losses recognized for the years ended June 30, 2023, and June 30, 2024[61] - The company has established a long-term relationship with banks and is confident in renewing bank borrowings of approximately HKD 4,900,000 upon maturity[82] Operational Changes and Future Outlook - The company has suspended construction on development properties since August 2022, indicating a strategic shift in operations[43] - The coal mining business received government approval for its work and budget plan on December 31, 2023, with coal production expected to start in April 2024 and the first sale in May 2024[93] - The company anticipates additional cash flow from the full launch of new products and a recovery in electric toothbrush sales in the coming year[82] - The company plans to implement revolutionary production designs to achieve maximum cost efficiency in terms of production volume and quality[82] - The company is considering legal action to recover receivables and may sell them to collection agencies or asset management companies due to ongoing litigation[58] Auditor's Concerns and Management Response - The auditor has issued a qualified opinion on the accuracy of bank borrowings and related financing costs due to lack of feedback from banks[77] - The management acknowledges the uncertainty regarding the recoverability of other receivables and accepts the auditor's qualified opinion on this matter[74] - The management believes that the qualified opinions have been fully addressed following the completion of the sale of relevant interests[80] Employee and Dividend Information - The group employed 588 staff as of June 30, 2024, with 20 in Hong Kong, 567 in China, and 1 in Indonesia[116] - The board did not recommend any dividend payment for the year ending June 30, 2024, consistent with the previous year[119]

中證國際有限公司 中期 報 告 2023/2024 2 簡明綜合損益及其他全面收益表 截至二零二三年十二月三十一日止六個月 | | | 截至下列日期止六個月 | | | --- | --- | --- | --- | | | | 二零二三年 | 二零二二年 | | | | 十二月三十一日 | 十二月三十一日 | | | 附註 | 千港元 | 千港元 | | | | （未經審核） | （未經審核） | | 收益 | | 83,786 | 745,823 | | 利息收益 | | 284 | 653 | | 收益總額 | 4 | 84,070 | 746,476 | | 銷售成本 | | (78,262) | (548,344) | | 毛利 | | 5,808 | 198,132 | | 其他收入及其他收益及虧損 | 5 | 6,151 | 10,926 | | 銷售及分銷開支 | | (1,613) | (9,796) | | 行政開支 | | (31,767) | (57,760) | | 經營（虧損）╱溢利 | | (21,421) | 141,502 | | 應收聯營公司款項之減值虧損 | 12 | ( ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不對因本公佈全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 ZHONGZHENG INTERNATIONAL COMPANY LIMITED 中證國際有限公司 （於百慕達註冊成立之有限公司） （股份代號：943） 有關截至二零二三年十二月三十一日止六個月之初步中期業績公 佈之澄清公佈 謹此提述中證國際有限公司（「本公司」）日期為二零二四年二月二十九日之公佈， 內容有關本公司及其附屬公司截至二零二三年十二月三十一日止六個月之初步中 期業績（「中期業績公佈」）。除文義另有所指外，本公佈所採用之詞彙與中期業績 公佈所界定者具有相同涵義。 本公司謹此澄清，由於手民之誤，第二頁簡明綜合損益及其他全面收益表中截至 二零二三年十二月三十一日止六個月之所得稅抵免╱（開支）「（24,093）」應為 「24,093」，而第9頁簡明綜合財務報表附註7之所得稅（抵免）╱開支應載列如下（修 改處用下劃線標出）： 「 | | 截至十二月三十一日止六個月 | | | --- | --- | - ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不對因本公佈全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 ZHONGZHENG INTERNATIONAL COMPANY LIMITED 中證國際有限公司 （於百慕達註冊成立之有限公司） （股份代號：943） 截至二零二三年十二月三十一日止六個月之 初步中期業績公佈 未經審核中期業績 中證國際有限公司（「本公司」）董事會（「董事會」）欣然公佈本公司及其附屬公司（「本 集團」）於截至二零二三年十二月三十一日止六個月（「本期間」）之未經審核中期業 績連同截至二零二二年十二月三十一日止六個月之未經審核比較數字如下： 簡明綜合損益及其他全面收益表 截至二零二三年十二月三十一日止六個月 | | | 截至下列日期止六個月 | | | --- | --- | --- | --- | | | | 二零二三年 | 二零二二年 | | | | 十二月三十一日 | 十二月三十一日 | | | 附註 | 千港元 | 千港元 | | | | （未經審核） | （未經審核） | | 收益 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不對因本公佈全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 ZHONGZHENG INTERNATIONAL COMPANY LIMITED 中證國際有限公司 （於百慕達註冊成立之有限公司） （股份代號：943） 截至二零二二年六月三十日止十八個月之 未經審核全年業績公佈 未經審核全年業績 謹此提述中證國際有限公司（「本公司」）日期為二零二二年十月三日之公佈，內容 有關（其中包括）延遲刊發本公司及其附屬公司（統稱「本集團」）截至二零二二年 六月三十日止十八個月之經審核全年業績及刊發截至二零二二年六月三十日止 十八個月之未經審核全年業績。 因此，本公司董事（「董事」）會（「董事會」）謹此公佈以下本集團截至二零二二年六 月三十日止十八個月（「本期間」）之初步未經審核綜合財務資料連同上年度的比較 數字。初步未經審核綜合財務報表涵蓋截至二零二二年六月三十日止十八個月期 間，而比較財務報表涵蓋截至二零二零年十二月三十一日止十二個月期間。因此， 比較數字並不完全可供比較。董事 ...

Financial Performance - Total revenue for the year ended December 31, 2021, was HKD 130,340,000, a decrease of 15.7% compared to HKD 154,692,000 in 2020[8] - The company reported a loss of HKD 322,933,000 for the year, significantly higher than the loss of HKD 67,192,000 in the previous year[10] - Gross profit for the year was HKD 29,538,000, down from HKD 44,772,000 in 2020, reflecting a gross margin decline[8] - The company reported a total comprehensive loss of HKD 338,703,000 for the year, compared to a comprehensive loss of HKD 13,604,000 in 2020[10] - Revenue from the healthcare and household products segment for the year ended December 31, 2021, was HKD 125,505,000, down from HKD 149,768,000 in 2020, representing a decrease of approximately 16.1%[26] - The total impairment loss recognized for the assets of the disposed group was HKD 101,556,000 for the year ended December 31, 2021[35] - The company recorded a total loss from discontinued operations of HKD 256,239,000 for the year ended December 31, 2021, compared to a profit of HKD 6,527,000 in 2020[35] - The consolidated loss for the twelve months ended December 31, 2021, was approximately HKD 322,933,000, compared to a loss of about HKD 67,192,000 in the same period of 2020[61] Assets and Liabilities - The company’s total assets decreased to HKD 3,561,981,000 from HKD 4,104,103,000 in the previous year[13] - The net asset value decreased to HKD 1,085,697,000 from HKD 1,424,893,000, reflecting a decline in overall equity[15] - Non-current assets totaled HKD 789,855,000, down from HKD 1,404,103,000 in the previous year, indicating a reduction in long-term investments[13] - The company’s cash and cash equivalents decreased to HKD 177,095,000 from HKD 1,559,362,000, highlighting liquidity challenges[13] - The company’s debt and borrowings totaled approximately HKD 314,027,000 as of December 31, 2021, a decrease from HKD 1,382,133,000 as of December 31, 2020[93] - The company’s debt ratio was 28.9% as of December 31, 2021, significantly improved from 97.0% as of December 31, 2020[94] Cash Flow - The net cash generated from operating activities for the year ended December 31, 2021, was HKD 195,351,000, compared to a net cash outflow of HKD 44,782,000 in 2020[19] - The net cash used in investing activities was HKD 224,875,000 for the year ended December 31, 2021, compared to HKD 87,086,000 in 2020[19] - The net cash generated from financing activities increased to HKD 156,110,000 in 2021 from HKD 104,547,000 in 2020[19] - The total cash and cash equivalents at the end of 2021 were HKD 346,662,000, up from HKD 177,095,000 at the end of 2020[19] Business Operations - The company plans to terminate its property development and first-level land development business following the sale of its wholly-owned subsidiary, Hong Kong Zhongzheng City Investment Co., Ltd.[20] - The company is focused on manufacturing and selling health and household products, as well as lending and mining operations[20] - The company has signed a commercial agreement with a well-known international health brand for an electric beauty device project, potentially generating sales of up to HKD 312,000,000 over three years[90] - The company has commenced mass production of new projects related to adult electric toothbrushes and UV sterilizers, with expected total sales of approximately HKD 71,000,000 for the year[90] Governance and Compliance - The company’s financial statements are prepared in accordance with Hong Kong Accounting Standards, ensuring compliance with local regulations[22] - The audit committee, composed of independent non-executive directors, is responsible for reviewing the financial reporting process and internal controls[112] - The company has complied with all provisions of the corporate governance code, except for the specific provision regarding the term of non-executive directors[109] - The board consists of four executive directors and three independent non-executive directors, indicating a balanced governance structure[113] Shareholder Information - Major shareholders include Liang Songshan with 4,233,534,634 shares (39.48%), Lim Kim Chai with 1,569,420,951 shares (14.64%), and Qiu Qing with 1,259,861,773 shares (11.75%) as of December 31, 2021[104] - The total number of shares available for issuance under the 2015 Share Option Scheme is 96,186,832, representing 0.90% of the issued shares as of the report date[103] Employment and Workforce - As of December 31, 2021, the company had 20 employees in Hong Kong, 593 in China, and 1 in Indonesia, reflecting a decrease from 29, 671, and 1 employees respectively in 2020[97]